FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to pharmacology and pharmaceutical industry and concerns a method for preparing a solid dosage form of Tameron in the form of solid enteric capsules filled with granules or modified release granules containing an active pharmaceutical substance sodium aminodihydrophthalazinedione. Granules for filling have the following versions of composition. Composition 1, wt.%: sodium aminodihydrophthalazinedione: 25–35; hydroxypropyl cellulose: 1–10, or hydroxymethyl cellulose: 1–10, or hydroxypropyl methylcellulose: 1–10; colloidal silicon dioxide: 1; magnesium stearate: 1; mannitol: up to 100 or sorbitol: up to 100. Composition 2: wt.%: sodium aminodihydrophthalazinedione: 25–35; hydroxypropyl cellulose: 1–10, or hydroxymethyl cellulose: 1–10, or hydroxypropyl methylcellulose: 1–10; polyvinylpyrrolidone: 1–5; dextran: 3–25, or sodium alginate: 3–25, or chitosan: 3–25; colloidal silicon dioxide: 1%; magnesium stearate: 1%; mannitol: up to 100% or sorbitol: up to 100%. Technical result consists in preparing a solid form of a drug preparation Tameron based on sodium aminodihydrophthalazinedione in the form of solid enteric capsules, which nucleus is composed of granules or granules with modified release, which provides the possibility of using various technologies of capsule filling by means of manual, semi-automatic and automatic methods.
EFFECT: ease of use of the preparation Tameron, manufacturability, preservation of biological activity and physical properties of the preparation, storage stability, high bioavailability, safety of use and efficacy of releasing the medicinal substance of the given dosage form.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774597C1 |
SOLID ENTERIC ORAL DOSAGE FORM OF PROINSULIN C-PEPTIDE (VERSIONS) AND METHOD FOR PREPARING IT (VERSIONS) | 2013 |
|
RU2522897C1 |
RADIOPROTECTIVE, RADIOMITIGATORY AND RADIOSENSITIZING AGENT BASED ON SODIUM SALT OF AMINODIHYDROPHTHALAZINEDIONE SODIUM (DRUG TAMERON) AND OTHER ALKALI AND ALKALINE EARTH METAL SALTS OF AMINODIHYDROPHTHALAZINEDIONE | 2022 |
|
RU2804886C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
ORALLY ADMINISTERED PHARMACEUTICAL GRANULE OF EPIDERMAL GROWTH FACTOR | 2011 |
|
RU2540503C2 |
ORAL COMPOSITION CONTAINING NONPATHOGENIC MICROORGANISMS SHOWING ABILITY TO NORMALISE INTESTINAL MICROFLORA (VERSIONS) | 2008 |
|
RU2453320C2 |
DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774615C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457857C2 |
Authors
Dates
2024-09-24—Published
2023-05-29—Filed